Appelboom, T., Schuermans, J., Verbruggen, G., Henrotin, Y., and Reginster, J. Y. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scand J Rheumatol 2001;30(4):242-247. View abstract.
Blotman, F., Maheu, E., Wulwik, A., Caspard, H., and Lopez, A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rhum Engl Ed 1997;64(12):825-834. View abstract.
Aguila MB, Sa Silva SP, Pinheiro AR, Mandarim-de-Lacerda CA. Effects of long-term intake of edible oils on hypertension and myocardial and aortic remodelling in spontaneously hypertensive rats. J Hypertens 2004;22:921-9. View abstract.
Baer DJ, Henderson T, Gebauer SK. Consumption of high-oleic soybean oil improves lipid and lipoprotein profile in humans compared to a palm oil blend: A randomized controlled trial. Lipids 2021;56(3):313-325. View abstract.
Bardare M, Magnolfi C, Zani G. Soy sensitivity: personal observation on 71 children with food intolerance. Allerg Immunol (Paris) 1988;20:63-6.
Duenas-Laita A, Pineda F, Armentia A. Hypersensitivity to generic drugs with soybean oil. N Engl J Med 2009;361(13):1317-8. View abstract.
Eigenmann PA, Burks AW, Bannon GA, et al. Identification of unique peanut and soy allergens in sera adsorbed with cross-reacting antibodies. J Allergy Clin Immunol 1996;98:969-78. View abstract.
FDA completes review of qualified health claim petition for oleic acid and the risk of coronary heart disease. November 2018. Available at: www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm624758.htm. Accessed January 25, 2019.
Abid S, Mumtaz K Abbas Z Hamid S Jafri N Ali Shah H Jafri W. Efficacy of infusion of L-ornithine L-aspartate in cirrhotic patients with portosystemic encephalopathy: a placebo controlled study. Journal of Hepatology. 2005;42 (Supp 2):84.
Acharya, S. K., Bhatia, V., Sreenivas, V., Khanal, S., and Panda, S. K. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 2009;136(7):2159-2168. View abstract.
Ahmad, I., Khan, A. A., Alam, A., Dilshad, A., Butt, A. K., Shafqat, F., Malik, K., and Sarwar, S. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. J.Coll.Physicians Surg.Pak. 2008;18(11):684-687. View abstract.
Anon. Therapeutic efficacy of oral L-ornithine-L-aspartate on minimal encephalopathy. EBM Reviews - Cochrane Central Register of Controlled Trials. 2008;ClinicalTrials.gov
Stauch S, Rosch W. Effects of L-ornithine-L-aspartate granulate on hyperammonemia in cirrhotic patients with hepatic encephalopathy (HE). A placebo-controlled double-blind study. Zeitschrift fur Gastroenterologie. 1992;30(4):300-301.
Stauch, S., Kircheis, G., Adler, G., Beckh, K., Ditschuneit, H., Gortelmeyer, R., Hendricks, R., Heuser, A., Karoff, C., Malfertheiner, P., Mayer, D., Rosch, W., and Steffens, J. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J.Hepatol. 1998;28(5):856-864. View abstract.
Stechmiller, J. K., Childress, B., and Cowan, L. Arginine supplementation and wound healing. Nutr.Clin.Pract. 2005;20(1):52-61. View abstract.
Sugino, T., Shirai, T., Kajimoto, Y., and Kajimoto, O. L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutr.Res. 2008;28(11):738-743. View abstract.
Tsai B-H, Lee N-Y. Effect of arginine and ornithine supplementation on weightlifters' fat free mass and anaerobic power. Nutritional Sciences Journal. 1997;22(4):373-383.
Yuan, Wenming. Li Jing. Xu Lin. Zhang Mingming. Lu Zhenchan. Feng Shejun. Wang Ling. L-ornithine-L-aspartate for hepatic encephalopathy. Cochrane Hepato-Biliary Group Cochrane Database of Systematic Reviews. 2009;
Bucci LR, Hickson JF Jr, Wolinsky I, Pivarnik JM. Ornithine supplementation and insulin release in bodybuilders. Int J Sport Nutr 1992;2:287-91. View abstract.
Fogelholm GM, Naveri HK, Kiilavuori KT, Harkonen MH. Low-dose amino acid supplementation: no effects on serum human growth hormone and insulin in male weightlifters. Int J Sport Nutr 1993;3:290-7. View abstract.
Fukuda T, Haraguchi A, Takahashi M, et al. A randomized, double-blind and placebo-controlled crossover trial on the effect of l-ornithine ingestion on the human circadian clock. Chronobiol Int 2018;35(10):1445-55. View abstract.
Hol JW, van Lier F, Valk M, Klimek M, Stolker RJ, Fekkes D. Effect of major and minor surgery on plasma levls of arginine, citrulline, nitric oxide metabolites, and ornithine in humans. Ann Surg 2013;258(6):1072-8. View abstract.
Horiuchi M, Kanesada H, Miyata T, et al. Ornithine ingestion improved sleep disturbances but was not associated with correction of blood tryptophan ratio in Japanese Antarctica expedition members
during summer. Nutr Res 2013;33(7):557-64.
View abstract.
Ito N, Seki S, Ueda F. Effects of Composite Supplement Containing Collagen Peptide and Ornithine on Skin Conditions and Plasma IGF-1 Levels-A Randomized, Double-Blind, Placebo-Controlled Trial. Mar Drugs. 2018;16(12). pii: E482. View abstract.
Manufacturer: Twinlab. Ronkonkoma, NY.
Miura N, Morishita K, Yasuda T, Akiduki S, Matsumoto H. Subchronic tolerance trials of graded oral supplementation with ornithine hydrochloride or citrulline in healthy adults. Amino Acids 2023;55(3):299-311. View abstract.
Miyake M, Kirisako T, Kokubo T, et al. Randomised controlled trial of the effects of L-ornithine on stress markers and sleep quality in healthy workers. Nutr J 2014;13:53. View abstract.
Rees C, Oppong K, Mardini H, et al. Effect of L-Ornithine-L-Aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut 2000;47:571-4.. View abstract.
Schmid M, Peck-Radosavljevic M König F Mittermaier C Gangl A Ferenci P. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver Int. 2010;30(4):574-582. View abstract.
Shynkevych VI, Kolomiiets SV, Kaidashev IP. Effects of l-arginine and l-ornithine supplementations on the treatment of chronic periodontitis: A preliminary randomized short-term clinical trial. Heliyon. 2021;7(11):e08353. View abstract.
Takakura M, Nagamachi S, Nishigawa T, Takahashi Y, Furuse M. Supplementation of L-Ornithine Could Increase Sleep-like Behavior in the Mouse Pups. Metabolites 2022;12(12):1241. View abstract.
Taniguchi E, Hattori A, Kurogi K, et al. Temporal patterns of increased growth hormone secretion in mice after oral administration of L-ornithine: possible involvement of ghrelin receptors. J Vet Med Sci 2022;84(9):1283-1287. View abstract.
Zajac A, Poprzecki S, Zebrowska A, Chalimoniuk M, Langfort J. Arginine and ornithine supplementation increases growth hormone and insulin-like growth factor-1 serum levels after heavy-resistance exercise in strength-trained athletes. J Strength Cond Res 2010;24(4):1082-90. View abstract.